| Literature DB >> 35577571 |
Jennifer Kizza1, Richard J Lu1, Jonah Zuflacht2, Marc Bouffard1.
Abstract
Visual hallucinations are frequently encountered in clinical practice. It is critical for neurologists, particularly those in training, to develop a systematic approach for evaluating patients presenting with such unique and often perplexing symptoms. Here, we present the case of a 48-year-old woman who developed vivid visual hallucinations after receiving nivolumab for melanoma. We discuss the broad differential diagnosis for visual hallucinations and how the history and examination can guide one's evaluation.Entities:
Year: 2022 PMID: 35577571 PMCID: PMC9421773 DOI: 10.1212/WNL.0000000000200806
Source DB: PubMed Journal: Neurology ISSN: 0028-3878 Impact factor: 11.800